Annual D&A
$164.00 K
-$336.00 K-67.20%
31 December 2023
Summary:
Esperion Therapeutics annual depreciation & amortization is currently $164.00 thousand, with the most recent change of -$336.00 thousand (-67.20%) on 31 December 2023. During the last 3 years, it has fallen by -$383.00 thousand (-70.02%). ESPR annual D&A is now -73.20% below its all-time high of $612.00 thousand, reached on 31 December 2021.ESPR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$26.00 K
+$16.00 K+160.00%
30 September 2024
Summary:
Esperion Therapeutics quarterly depreciation & amortization is currently $26.00 thousand, with the most recent change of +$16.00 thousand (+160.00%) on 30 September 2024. Over the past year, it has stayed the same.ESPR quarterly D&A is now -84.05% below its all-time high of $163.00 thousand, reached on 30 September 2020.ESPR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$42.00 K
$0.000.00%
30 September 2024
Summary:
Esperion Therapeutics TTM depreciation & amortization is currently $42.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$208.00 thousand (-83.20%). ESPR TTM D&A is now -93.32% below its all-time high of $629.00 thousand, reached on 30 June 2021.ESPR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.2% | 0.0% | -83.2% |
| 3 y3 years | -70.0% | -83.0% | -93.2% |
| 5 y5 years | -38.1% | -71.7% | -85.6% |
ESPR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -73.2% | at low | -83.0% | -93.2% | at low | |
| 5 y | 5 years | -73.2% | at low | -84.0% | -93.3% | at low | |
| alltime | all time | -73.2% | +108.0% | -84.0% | -93.3% | +13.8% |
Esperion Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $26.00 K(+160.0%) | $42.00 K(0.0%) |
| June 2024 | - | $10.00 K(>+9900.0%) | $42.00 K(-49.4%) |
| Mar 2024 | - | $0.00(-100.0%) | $83.00 K(-49.4%) |
| Dec 2023 | $164.00 K(-67.2%) | $6000.00(-76.9%) | $164.00 K(-34.4%) |
| Sept 2023 | - | $26.00 K(-49.0%) | $250.00 K(-24.0%) |
| June 2023 | - | $51.00 K(-37.0%) | $329.00 K(-23.1%) |
| Mar 2023 | - | $81.00 K(-12.0%) | $428.00 K(-14.4%) |
| Dec 2022 | $500.00 K(-18.3%) | $92.00 K(-12.4%) | $500.00 K(-10.9%) |
| Sept 2022 | - | $105.00 K(-30.0%) | $561.00 K(-7.9%) |
| June 2022 | - | $150.00 K(-2.0%) | $609.00 K(-0.5%) |
| Mar 2022 | - | $153.00 K(0.0%) | $612.00 K(0.0%) |
| Dec 2021 | $612.00 K(+11.9%) | $153.00 K(0.0%) | $612.00 K(-1.1%) |
| Sept 2021 | - | $153.00 K(0.0%) | $619.00 K(-1.6%) |
| June 2021 | - | $153.00 K(0.0%) | $629.00 K(+5.9%) |
| Mar 2021 | - | $153.00 K(-4.4%) | $594.00 K(+8.6%) |
| Dec 2020 | $547.00 K(+71.5%) | $160.00 K(-1.8%) | $547.00 K(+12.1%) |
| Sept 2020 | - | $163.00 K(+38.1%) | $488.00 K(+17.0%) |
| June 2020 | - | $118.00 K(+11.3%) | $417.00 K(+17.8%) |
| Mar 2020 | - | $106.00 K(+5.0%) | $354.00 K(+11.0%) |
| Dec 2019 | $319.00 K(+20.4%) | $101.00 K(+9.8%) | $319.00 K(+9.2%) |
| Sept 2019 | - | $92.00 K(+67.3%) | $292.00 K(+9.4%) |
| June 2019 | - | $55.00 K(-22.5%) | $267.00 K(-2.9%) |
| Mar 2019 | - | $71.00 K(-4.1%) | $275.00 K(+3.8%) |
| Dec 2018 | $265.00 K(+2.7%) | $74.00 K(+10.4%) | $265.00 K(+4.7%) |
| Sept 2018 | - | $67.00 K(+6.3%) | $253.00 K(+2.0%) |
| June 2018 | - | $63.00 K(+3.3%) | $248.00 K(-0.8%) |
| Mar 2018 | - | $61.00 K(-1.6%) | $250.00 K(-3.1%) |
| Dec 2017 | $258.00 K | $62.00 K(0.0%) | $258.00 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $62.00 K(-4.6%) | $258.00 K(-0.4%) |
| June 2017 | - | $65.00 K(-5.8%) | $259.00 K(+0.8%) |
| Mar 2017 | - | $69.00 K(+11.3%) | $257.00 K(+2.0%) |
| Dec 2016 | $252.00 K(+6.8%) | $62.00 K(-1.6%) | $252.00 K(-1.9%) |
| Sept 2016 | - | $63.00 K(0.0%) | $257.00 K(+3.6%) |
| June 2016 | - | $63.00 K(-1.6%) | $248.00 K(+2.9%) |
| Mar 2016 | - | $64.00 K(-4.5%) | $241.00 K(+2.1%) |
| Dec 2015 | $236.00 K(+47.5%) | $67.00 K(+24.1%) | $236.00 K(+4.9%) |
| Sept 2015 | - | $54.00 K(-3.6%) | $225.00 K(+1.4%) |
| June 2015 | - | $56.00 K(-5.1%) | $222.00 K(+7.2%) |
| Mar 2015 | - | $59.00 K(+5.4%) | $207.00 K(+29.4%) |
| Dec 2014 | $160.00 K(+125.4%) | $56.00 K(+9.8%) | $160.00 K(+39.1%) |
| Sept 2014 | - | $51.00 K(+24.4%) | $115.00 K(+53.3%) |
| June 2014 | - | $41.00 K(+241.7%) | $75.00 K(+47.1%) |
| Mar 2014 | - | $12.00 K(+9.1%) | $51.00 K(-28.2%) |
| Dec 2013 | $71.00 K(-48.9%) | $11.00 K(0.0%) | $71.00 K(-22.9%) |
| Sept 2013 | - | $11.00 K(-35.3%) | $92.10 K(-20.6%) |
| June 2013 | - | $17.00 K(-46.9%) | $116.00 K(-13.5%) |
| Mar 2013 | - | $32.00 K(-0.3%) | $134.10 K(-3.5%) |
| Dec 2012 | $139.00 K(-22.1%) | $32.10 K(-8.0%) | $139.00 K(+30.0%) |
| Sept 2012 | - | $34.90 K(-0.6%) | $106.90 K(+48.5%) |
| June 2012 | - | $35.10 K(-4.9%) | $72.00 K(+95.1%) |
| Mar 2012 | - | $36.90 K | $36.90 K |
| Dec 2011 | $178.50 K(-113.8%) | - | - |
| Dec 2002 | -$1.29 M(-35.9%) | - | - |
| Dec 2001 | -$2.01 M(-1.8%) | - | - |
| Dec 2000 | -$2.05 M(+200.1%) | - | - |
| Dec 1999 | -$683.00 K | - | - |
FAQ
- What is Esperion Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Esperion Therapeutics?
- What is Esperion Therapeutics annual D&A year-on-year change?
- What is Esperion Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly D&A year-on-year change?
- What is Esperion Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Esperion Therapeutics?
- What is Esperion Therapeutics TTM D&A year-on-year change?
What is Esperion Therapeutics annual depreciation & amortization?
The current annual D&A of ESPR is $164.00 K
What is the all time high annual D&A for Esperion Therapeutics?
Esperion Therapeutics all-time high annual depreciation & amortization is $612.00 K
What is Esperion Therapeutics annual D&A year-on-year change?
Over the past year, ESPR annual depreciation & amortization has changed by -$336.00 K (-67.20%)
What is Esperion Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ESPR is $26.00 K
What is the all time high quarterly D&A for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly depreciation & amortization is $163.00 K
What is Esperion Therapeutics quarterly D&A year-on-year change?
Over the past year, ESPR quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Esperion Therapeutics TTM depreciation & amortization?
The current TTM D&A of ESPR is $42.00 K
What is the all time high TTM D&A for Esperion Therapeutics?
Esperion Therapeutics all-time high TTM depreciation & amortization is $629.00 K
What is Esperion Therapeutics TTM D&A year-on-year change?
Over the past year, ESPR TTM depreciation & amortization has changed by -$208.00 K (-83.20%)